2025 annual financial data
X4 Pharmaceuticals 2025 Operating margin
X4 Pharmaceuticals 2025 operating margin with verified reported values.
Direct answer
Operating margin was -247.44%.
Operating income was -86,883,000 USD and net income was -79,199,000 USD.
Operating cash flow was -85,618,000 USD.
Get free X4 Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 35,113,000 USD
- Operating income
- -86,883,000 USD
- Net income
- -79,199,000 USD
- Operating cash flow
- -85,618,000 USD